Effective Strategies for the Non-Adherent Buprenorphine Patient: Rational Monitoring and Contingency
Worried about prescribing buprenorphine for addiction? ...about patient misuse or diversion? In this webinar, we provide a simple framework to conceptualize the doctor-patient relationship which can empower you to remain in a compassionate stance toward risky or non-adherent patients, while also helping them modify their behavior toward safer and more appropriate use. You will learn how to interpret the prescription drug monitoring database, and urine toxicology tests, and integrate them in your practice. More importantly, you will find out what to do when these screening tests come up positive … without having to resort to rejection or retaliation, or experiencing feelings of burnout." Recorded 1/27/2017
ASAM and/or CSAM Members: Free
You must register on this site before purchasing using the link on the upper right corner of this page. Only after registering will you see the "Add to Cart" button. To purchase, scroll to the bottom of the page and choose your purchase option (member/non-member) and click "Add to Cart."
This enduring internet activity is jointly provided by the California Society of Addiction Medicine (CSAM) and the California Health Care Foundation. CSAM is accredited by the Institute for Medical Quality/California Medical Association to provide continuing medical education for physicians. CSAM takes responsibility for the content, quality and scientific integrity of this CME activity.
CSAM designates this live educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™ Physicians should only claim credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA Certification in Continuing Medical Education.
PA’s, nurses, pharmacists, psychologists and therapists can earn CEU credit.
Anna Lembke, MD,
Director, Stanford Addiction Medicine Program and Chief, Stanford Addiction Medicine Clinic, Stanford University School of Medicine, Palo Alto
Greg Skipper, MD
Director, Professionals Health Services, Professionals Treatment at Promises, Malibu
None of the facukty or planners have any relevant financial relationships to dosclose.
- 1.00 Attendance
- 1.00 AMA Category 1
- Apply behavioral economics and the Prisoner’s Dilemma to understand the non-adherent patient taking buprenorphine (or other controlled medications)
- Integrate monitoring tools such as the prescription drug monitoring database and urine toxicology with the non-adherent buprenorphine patient
- Employ Tit for Tat as a strategy for moving the non-adherent buprenorphine patient toward better compliance and improved health